management of platinum resistant ovarian cancer, detailed overview using all evidences, including latest evidences, choice of chemotherapy, factors deciding choice of chemotherapy.using tables and flowcharts wherever required give the document in pdf format.
"platinum-resistant ovarian cancer" AND treatment
platinum resistant ovarian cancer management guidelines 2024 2025 chemotherapy options
PMID: 38055253
PMID: 40473448
https://pmc.ncbi.nlm.nih.gov/articles/PMC12411830
PMID: 38218775
PMID: 37906726
PMID: 38635934
mirvetuximab soravtansine FDA approval ESMO 2024 platinum resistant ovarian cancer MIRASOL
mkdir -p /home/daytona/workspace/proc-guide && ls /home/daytona/workspace/
Please make above pdf
Continue
mkdir -p /home/daytona/workspace/proc-guide